Compile Data Set for Download or QSAR
Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 12366
TargetShort transient receptor potential channel 5(Human)
Wuhan LL Science and Technology Development Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 698777BDBM698777(US20240317755, Compound L002)
Affinity DataIC50: 6.52nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetShort transient receptor potential channel 5(Human)
Wuhan LL Science and Technology Development Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 698778BDBM698778(US20240317755, Compound L007)
Affinity DataIC50: 7.37nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetShort transient receptor potential channel 5(Human)
Wuhan LL Science and Technology Development Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 698776BDBM698776(US20240317755, Compound L001)
Affinity DataIC50: 10.8nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetShort transient receptor potential channel 5(Human)
Wuhan LL Science and Technology Development Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 698782BDBM698782(US20240317755, Compound L015)
Affinity DataIC50: 11.5nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetShort transient receptor potential channel 5(Human)
Wuhan LL Science and Technology Development Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 698780BDBM698780(US20240317755, Compound L013)
Affinity DataIC50: 14.6nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetShort transient receptor potential channel 5(Human)
Wuhan LL Science and Technology Development Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 698781BDBM698781(US20240317755, Compound L014)
Affinity DataIC50: 18.2nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetShort transient receptor potential channel 5(Human)
Wuhan LL Science and Technology Development Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 698783BDBM698783(US20240317755, Compound L019)
Affinity DataIC50: 24nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetShort transient receptor potential channel 5(Human)
Wuhan LL Science and Technology Development Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 698779BDBM698779(US20240317755, Compound L009)
Affinity DataIC50: 39.4nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent